[ERI3 expression is elevated in hepatocellular carcinoma and correlates with poor patient prognosis].
1/5 보강
[OBJECTIVES] To analyze the expression pattern of Exoribonuclease Family Member 3 (ERI3) in hepatocellular carcinoma (HCC) tissues and its influences on long-term prognosis and cancer cell metastasis.
- HR 2.86
APA
Zhao X, Wang H, et al. (2026). [ERI3 expression is elevated in hepatocellular carcinoma and correlates with poor patient prognosis].. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 46(1), 175-182. https://doi.org/10.12122/j.issn.1673-4254.2026.01.19
MLA
Zhao X, et al.. "[ERI3 expression is elevated in hepatocellular carcinoma and correlates with poor patient prognosis].." Nan fang yi ke da xue xue bao = Journal of Southern Medical University, vol. 46, no. 1, 2026, pp. 175-182.
PMID
41540704 ↗
Abstract 한글 요약
[OBJECTIVES] To analyze the expression pattern of Exoribonuclease Family Member 3 (ERI3) in hepatocellular carcinoma (HCC) tissues and its influences on long-term prognosis and cancer cell metastasis.
[METHODS] Based on the TCGA-LIHC dataset (including 377 HCC and 50 adjacent normal tissues), the differential expression of ERI3 was analyzed using DESeq2, and the results were validated using immunohistochemical data from the HPA database. A protein-protein interaction network was constructed using STRING and GeneMANIA. The prognostic value of ERI3 was assessed by Cox regression and Kaplan-Meier (KM) survival analyses, its diagnostic efficacy evaluated by ROC curve analysis, and its correlation with immune infiltration analyzed with ssGSEA algorithm. A nomogram prognostic model was established using multivariate Cox regression. For functional validation of ERI3 , a human HCC cell line SMMC-7721 with ERI3 knockdown was constructed, and the changes in cell proliferation, migration, and invasion were assessed using CCK-8, colony formation, wound healing, and Transwell assays.
[RESULTS] ERI3 was significantly overexpressed in HCC tissues (<0.001) and its expression levels increased progressively with advanced TNM stages (T1-T4: <0.001). In HCC patients, high ERI3 expressions were correlated with a reduced overall survival (HR=2.86, 95% : 1.68-4.88; <0.001), disease-specific survival (HR=2.27, =0.013), and progression-free interval (HR=1.83, =0.012). Diagnostic efficacy analysis revealed an AUC of 0.955 (95% : 0.931-0.978) for ERI3. Immune infiltration studies demonstrated a positive correlation of ERI3 expression level with Th2 cells (=0.340, <0.001) and a negative correlation with Th17 cells (=-0.284, <0.001). Multivariate Cox regression analysis identified ERI3 as an independent prognostic factor for HCC (HR=1.987, =0.003), and the constructed nomogram showed a good predictive accuracy (C-index=0.668). In SMMC-7721 cells, ERI3 knockdown significantly suppressed cell proliferation, migration, and invasion.
[CONCLUSIONS] ERI3 overexpression promotes HCC cell proliferation, migration, and invasion and is strongly linked to a poor prognosis of the patients.
[METHODS] Based on the TCGA-LIHC dataset (including 377 HCC and 50 adjacent normal tissues), the differential expression of ERI3 was analyzed using DESeq2, and the results were validated using immunohistochemical data from the HPA database. A protein-protein interaction network was constructed using STRING and GeneMANIA. The prognostic value of ERI3 was assessed by Cox regression and Kaplan-Meier (KM) survival analyses, its diagnostic efficacy evaluated by ROC curve analysis, and its correlation with immune infiltration analyzed with ssGSEA algorithm. A nomogram prognostic model was established using multivariate Cox regression. For functional validation of ERI3 , a human HCC cell line SMMC-7721 with ERI3 knockdown was constructed, and the changes in cell proliferation, migration, and invasion were assessed using CCK-8, colony formation, wound healing, and Transwell assays.
[RESULTS] ERI3 was significantly overexpressed in HCC tissues (<0.001) and its expression levels increased progressively with advanced TNM stages (T1-T4: <0.001). In HCC patients, high ERI3 expressions were correlated with a reduced overall survival (HR=2.86, 95% : 1.68-4.88; <0.001), disease-specific survival (HR=2.27, =0.013), and progression-free interval (HR=1.83, =0.012). Diagnostic efficacy analysis revealed an AUC of 0.955 (95% : 0.931-0.978) for ERI3. Immune infiltration studies demonstrated a positive correlation of ERI3 expression level with Th2 cells (=0.340, <0.001) and a negative correlation with Th17 cells (=-0.284, <0.001). Multivariate Cox regression analysis identified ERI3 as an independent prognostic factor for HCC (HR=1.987, =0.003), and the constructed nomogram showed a good predictive accuracy (C-index=0.668). In SMMC-7721 cells, ERI3 knockdown significantly suppressed cell proliferation, migration, and invasion.
[CONCLUSIONS] ERI3 overexpression promotes HCC cell proliferation, migration, and invasion and is strongly linked to a poor prognosis of the patients.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Heterogeneous Magnetic Resonance Nanoprobe for Assisting Liver Fibrosis Three-Dimensional Reconstruction and Cascaded Therapy.
- Performance of latest AI models, RAG, and MCP on lung cancer-related questions.
- Key molecules and functional subsets of regulatory T cells in maternal-fetal immune tolerance: Recent advances.
- Population pharmacokinetics and exposure-response analysis of durvalumab in patients with resectable stage II to IIIB (N2) NSCLC in the phase III AEGEAN study.
- CCDC137 stabilizes S100A6 to activate the PI3K/AKT pathway and drive acute myeloid leukemia progression.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.